• Please log in or register to access this feature.

Original Article

You have full text access to this OnlineOpen article

Mental health in men treated for early stage prostate carcinoma†

A posttreatment, longitudinal quality of life analysis from the cancer of the prostate strategic urologic research endeavor™

  1. Mark S. Litwin M.D., M.P.H.1,2,3,‡,*,
  2. Deborah P. Lubeck Ph.D.3,
  3. G. Mark Spitalny M.A.4,
  4. James M. Henning M.S.5,
  5. Peter R. Carroll M.D.3

Article first published online: 28 JUN 2002

DOI: 10.1002/cncr.10651

Issue

Cancer

Cancer

Volume 95, Issue 1, pages 54–60, 1 July 2002

Additional Information

How to Cite

Litwin, M. S., Lubeck, D. P., Spitalny, G. M., Henning, J. M. and Carroll, P. R. (2002), Mental health in men treated for early stage prostate carcinoma. Cancer, 95: 54–60. doi: 10.1002/cncr.10651

Author Information

  1. 1

    Department of Health Services, University of California, Los Angeles, California

  2. 2

    Department of Urology, University of California, Los Angeles, California

  3. 3

    Department of Urology, University of California, San Francisco, California

  4. 4

    Research Computing and Support Services, Sausalito, California

  5. 5

    TAP Pharmaceutical Products Inc., Lake Forest, Illinois

  1. ‡

    Fax: (310) 206 5343

*UCLA Department of Urology, P.O. Box 951738, Los Angeles, CA 90095-1738

  1. †

    CaPSURE™ is sponsored by TAP Pharmaceutical Products Inc. and managed by The Urology Outcomes Research Group at the University of California, San Francisco.

  2. ‡

    Fax: (310) 206 5343

Publication History

  1. Issue published online: 28 JUN 2002
  2. Article first published online: 28 JUN 2002
  3. Manuscript Accepted: 4 FEB 2002
  4. Manuscript Received: 30 NOV 2001

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (101K)

REFERENCES

  • 1
    da Silva FC. Quality of life in prostatic cancer patients. Cancer. 1993; 72(12 Suppl): 3803–3806.
    Direct Link:
  • 2
    Talcott JA. Quality of life in early prostate cancer. Do we know enough to treat? Hematol Oncol Clin North Am. 1996; 10: 691–701.
  • 3
    Altwein J, Ekman P, Barry M, et al. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology. 1997; 49(4A Suppl): 66–76.
  • 4
    Litwin MS. Measuring health related quality of life in men with prostate cancer. J Urol. 1994; 152 (5 Pt 2): 1882–1887.
  • 5
    Potosky AL, Harlan LC, Stanford JL, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999; 91: 1719–1724.
  • 6
    Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology. 1995; 45: 1007–1013.
  • 7
    Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol. 1996; 14: 2258–2265.
  • 8
    Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer. 1997; 79: 1977–1986.
    Direct Link:
  • 9
    Arai Y, Okubo K, Aoki Y, et al. Patient-reported quality of life after radical prostatectomy for prostate cancer. Int J Urol. 1999; 6: 78–86.
    Direct Link:
  • 10
    Yarbro CH, Ferrans CE. Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum. 1998; 25: 685–693.
  • 11
    Sprangers MA. Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials. Cancer Treat Rev, 1996; 22 Suppl A: 55–62.
  • 12
    Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. 1996; 14: 671–679.
  • 13
    Albertsen PC, Nease RF Jr., Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol. 1998; 159: 158–163.
  • 14
    Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA. 1993; 269: 2650–2658.
  • 15
    Beck JR, Kattan MW, Miles BJ. A critique of the decision analysis for clinically localized prostate cancer. J Urol. 1994; 152(5 Pt 2): 1894–1899.
  • 16
    Lubeck DP, Litwin MS, Henning JM, et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1996; 48: 773–777.
  • 17
    Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2: 217–227.
    Direct Link:
  • 18
    Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473–483.
  • 19
    Ware JE, Kosinski M, Keller SD. SF-12: How to score the SF-12 physical and mental health summary scales. Boston, MA: The Health Institute, New England Medical Center, 1995.
  • 20
    Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951; 16: 297–334.
  • 21
    Lubeck DP, Litwin MS, Henning JM, Carroll PR. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res. 1997; 6: 385–392.
  • 22
    Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995; 273: 129–135.
  • 23
    Litwin MS, Shpall AI, Dorey F, Nguyen TH. Quality-of-life outcomes in long-term survivors of advanced prostate cancer. Am J Clin Oncol. 1998; 21: 327–332.
  • 24
    Litwin MS. Health related quality of life in older men without prostate cancer. J Urol. 1999; 161: 1180–1184.
  • 25
    Ware JE, Kosinski M, Keller SK. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Center, 1994.
  • 26
    Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10: 407–415.
  • 27
    Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994; 47: 81–87.
  • 28
    Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993; 31: 141–154.
  • 29
    Krongrad A, Lai H, Burke MA, Goodkin K, Lai S. Marriage and mortality in prostate cancer. J Urol. 1996; 156: 1696–1702.
  • 1
    Penson DF, Litwin MS, Lubeck DP, Flanders S, Pasta DJ, Carroll PR. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prostate Cancer and Prostatic Diseases. 1998; 1: 134–143.
  • 31
    Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol. 1998; 16: 275–283.
  • 32
    Talcott JA, Rieker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 1997; 89: 1117–1123.
  • 33
    Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1999; 54: 503–508.
  • 34
    Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the cancer of the prostate strategic urologic research endeavor. J Urol. 2000; 164: 1973–1977.
  • 35
    D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969–974.
View Full Article (HTML) Get PDF (101K)